Genflow’s new research agreement with Magnitude Biosciences puts the company on track to drive research and pre-clinical drug discovery. Genflow …
Continue reading “Genflow Bio set to accelerate future therapeutic developments”
MitoRx Therapeutics’ CEO on how the small biotech already has several drug candidates for age-related diseases that target mitochondrial dysfunction. …
Biotech startup aims to reverse mitochondrial dysfunction to halt progression of degenerative disease. Longevity biotech startup MitoRx Therapeutics today announced …
Rejuvenate Biomed confirms it has started clinical trial with lead candidate RJx-01 for treating sarcopenia, expanded its team and moved …
The FOXO transcription factor can help in promoting stem cell multipotency during quiescence under adverse conditions, improving longevity, new research …
Continue reading “Foxo proteins get crafty when it comes to improving longevity”
A next-generation probiotic could promote healthy aging after positive results in worms, a new study shows. Back in 1907, Elie …
Continue reading “New probiotic that promotes longevity and healthy aging discovered”
Canadian skin rejuvenation start-up also spawns longevity biopharma company targeting inflammatory cytokines. Vancouver-based Derm-Biome Pharmaceuticals and its sister company, Pan-Biome …
Continue reading “Derm-Biome gears up for skin rejuvenation trial in 2022”
Protein tweaks can mean double, not quits, when it comes to life extension in worms new research shows. When it …
One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce …
Continue reading “An antiaging supplement that also reduces appetite?”
